Deletion of the C-terminal phosphorylation sites in the cardiac ?-subunit does not affect the basic ?-adrenergic response of the heart and the Ca(v)1.2 channel.
J Biol Chem
2012
287
27
22584-92
Distinct localization and modulation of Cav1.2 and Cav1.3 L-type Ca2+ channels in mouse sinoatrial node.
J Physiol
2012
590
Pt 24
6327-42
Identification of the degradation determinants of insulin receptor substrate 1 for signaling cullin-RING E3 ubiquitin ligase 7-mediated ubiquitination.
J Biol Chem
2012
287
48
40758-66
Mutation of the calmodulin binding motif IQ of the L-type Ca(v)1.2 Ca2+ channel to EQ induces dilated cardiomyopathy and death.
J Biol Chem
2012
287
27
22616-25
Pharmacases.de - a student-centered eLearning project of clinical pharmacology
Naunyn Schmiedebergs Arch Pharmacol
2012
385 1
79-79
Characterization of primary skin fibroblasts of patients with 3M syndrome and mutations in the CUL7 gene
Naunyn Schmiedebergs Arch Pharmacol
2012
385 1
79-79
The Gly389Arg polymorphism determines the activation kinetics of the human beta(1)-adrenergic receptor
Naunyn Schmiedebergs Arch Pharmacol
2012
385 1
4-4
Identification of novel targets of beta-adrenergic signaling through phosphoproteomics of the heart in vivo
Naunyn Schmiedebergs Arch Pharmacol
2012
385 1
29-30